Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.

Doctors gave 27 preschool and kindergarten kids liquid methylphenidate every morning for six weeks. All kids had both autism and ADHD. The dose started low and moved up only if parents saw better focus and no big side effects.

The team checked ADHD symptoms each week with standard rating scales. They also tracked sleep, eating, and any behavior spikes.

Low to moderate doses cut hyperactivity and impulsivity by half in most children. Gains showed up by week two and held steady.

Side effects were mild—mostly lower appetite at lunch and shorter naps. No child left the study because of problems.

Mhatre et al. (2016) followed Indian children with ASD for ten years and saw that early family engagement predicted better daily-living skills. Soo-Jeong adds that when ADHD is also present, a small dose of stimulant can give quick focus gains that may help those same daily skills.

Bado et al. (2023) showed Brazilian families wait months for behavioral parent training because services are scarce. The liquid medicine studied here could bridge that wait—behavior therapy plus low-dose stimulant may control symptoms faster than either alone.

Miller et al. (2016) warned that siblings of kids with ASD often show ADHD traits by school age. Our target study gives these families an evidence-based option if attention problems later appear.

You now have data showing liquid methylphenidate is safe and useful for preschoolers with both ASD and ADHD. If parents are on a therapy wait-list, you can discuss a short stimulant trial while they wait. Start low, watch appetite and sleep, and keep parent logs—simple steps that fit everyday ABA practice.